TWST

#1255
Twist Bioscience Corporation - Common Stock
66.8 7 USD
-3.13%
Setor: Cuidados de saúde
Base: USD
Moeda do lucro: USD
Faixa diária
66.87
66.87
Faixa anual
23.30
69.20
Mudança diária
-3.13%
Mudança mensal
+16.30%
Mudança em 6 meses
+114.05%
Mudança anual
+133.73%
Fechamento anterior
69.0 3
Open
66.8 7
Mínimo
66.8 7
High
66.8 7
Volume
165
Abrir gráfico completo Full chart

Financials

Visão geral Relatórios Estatísticas
Trimestral Ano
  • Market Capitalization 4.16 B
  • Employee 979
  • Founded 2013
  • CEO Emily LeProust
  • Website www.twistbioscience.com
  • Headquarter Delaware, United States
  • FIGI BBG006KDCHJ4
  • Industry Diagnósticos e pesquisa
Receita total
Lucro líquido
Lucro básico por ação
Dívida total
Fluxo de caixa livre
Caixa e equivalentes de caixa
Índice preço/lucro
-21.65
Índice preço/fluxo de caixa
4.47

Twist Bioscience Corporation - Common Stock

Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck. The company was represented by Leproust at a March 2021 tabletop exercise at the Munich Security Conference simulating an outbreak of weaponized monkeypox. In May 2021, Twist Bioscience and Genome Project-Write launched a new CAD platform for whole genome design. The CAD will automate workflows to enable collaborative efforts critical for scale-up from designing plasmids to megabases across entire genomes.

Notícias